Follow
Paul M Vanhoutte
Paul M Vanhoutte
Chair Professor in Pharmacology, University of Hong Kong
Verified email at hku.hk
Title
Cited by
Cited by
Year
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
D Hoyer, DE Clarke, JR Fozard, PR Hartig, GR Martin, EJ Mylecharane, ...
Pharmacological reviews 46 (2), 157-203, 1994
39921994
Endothelium‐derived relaxing and contracting factors
RF Furchgott, PM Vanhoutte
The FASEB Journal 3 (9), 2007-2018, 1989
27971989
Flow-induced release of endothelium-derived relaxing factor
GM Rubanyi, JC Romero, PM Vanhoutte
American Journal of Physiology-Heart and Circulatory Physiology 250 (6 …, 1986
21101986
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
GM Rubanyi, PM Vanhoutte
American Journal of Physiology-Heart and Circulatory Physiology 250 (5 …, 1986
18561986
Endothelial dysfunction in diabetes
AS De Vriese, TJ Verbeuren, J Van de Voorde, NH Lameire, ...
British journal of pharmacology 130 (5), 963-974, 2000
15072000
Endothelial dysfunction: a multifaceted disorder (the Wiggers Award Lecture)
M Félétou, PM Vanhoutte
American Journal of Physiology-Heart and Circulatory Physiology 291 (3 …, 2006
11512006
Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.
TF Lüscher, PM Vanhoutte
Hypertension 8 (4), 344-348, 1986
10801986
Endothelium-dependent hyperpolarization of canine coronary smooth muscle.
M Feletou, PM Vanhoutte
British journal of pharmacology 93 (3), 515, 1988
10741988
Anti-inflammatory actions of steroids: molecular mechanisms
PJ Barnes, I Adcock, M Spedding, PM Vanhoutte
Trends in pharmacological sciences 14 (12), 436-441, 1993
10711993
EDHF: bringing the concepts together
R Busse, G Edwards, M Félétou, I Fleming, PM Vanhoutte, AH Weston
Trends in pharmacological sciences 23 (8), 374-380, 2002
10652002
The endothelium: modulator of cardiovascular function
TF Luscher, PM Vanhoutte
CRC press, 2020
1062*2020
Endothelial dysfunction and vascular disease
PM Vanhoutte, H Shimokawa, EHC Tang, M Feletou
Acta physiologica 196 (2), 193-222, 2009
10262009
Endothelium and control of vascular function. State of the Art lecture.
PM Vanhoutte
Hypertension 13 (6_pt_2), 658-667, 1989
9591989
Endothelium-derived hyperpolarizing factor: where are we now?
M Félétou, PM Vanhoutte
Arteriosclerosis, thrombosis, and vascular biology 26 (6), 1215-1225, 2006
957*2006
Endothelial dysfunction and vascular disease–a 30th anniversary update
PM Vanhoutte, H Shimokawa, M Feletou, EHC Tang
Acta physiologica 219 (1), 22-96, 2017
9472017
Vascular nitric oxide: Beyond eNOS
Y Zhao, PM Vanhoutte, SWS Leung
Journal of pharmacological sciences 129 (2), 83-94, 2015
9392015
Modulation of vascular smooth muscle contraction by the endothelium
PM Vanhoutte, GM Rubanyi, VM Miller, DS Houston
Annual Review of Physiology 48 (1), 307-320, 1986
8891986
Endothelial dysfunction: from physiology to therapy
JV Mombouli, PM Vanhoutte
Journal of molecular and cellular cardiology 31 (1), 61-74, 1999
8281999
Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium.
JG De Mey, PM Vanhoutte
Circulation research 51 (4), 439-447, 1982
7931982
Endothelial dysfunction the first step toward coronary arteriosclerosis
PM Vanhoutte
Circulation Journal 73 (4), 595-601, 2009
7202009
The system can't perform the operation now. Try again later.
Articles 1–20